Starts: 2012-09-23 Ends: 2012-09-23
MYELOMA PATIENTS, FAMILIES AND FRIENDS
IN SAULT STE. MARIE JOIN WITH MYELOMA CANADA TO RAISE AWARENESS OF THIS INCURABLE CANCER, AND HIGHLIGHT IMPORTANT TREATMENT ADVANCES
Sault Ste. Marie Joins 10 Other Cities across Canada to Take Part in Multiple Myeloma Marches during National Blood Cancer Awareness Month
Sault Ste. Marie, September 12, 2012 –– Myeloma patients and families in Sault Ste. Marie will join other patients, families and friends in 10 other cities across six provinces who will be marching to “make myeloma matter”. Myeloma, also called multiple myeloma, is a blood cancer that affects cells in the bone marrow. Seven new cases are diagnosed each day in Canada and the disease remains incurable, but new treatments are providing new hope for patients. The marches raise awareness of this disease to make sure patients know the signs and where to get treatments, and they raise money for research and patient education programs. The Sault Ste. Marie march will take place on September 23rd during National Blood Cancer Awareness month.
In Sault Ste. Marie Jill Lang Ward will be co-leading the march. She was diagnosed in August 2007, at age 55. Jill is in remission for a second time, thanks to new treatments for this disease. She says, “I am living proof that we should never, never, never give up.”
Co-leading the Sault Ste. Marie march is Mike Caputo, research student with the Algoma District Cancer Program, in pre-med studies at Lake Superior State University. “Jill’s passion for progress in research and patient care inspired me to get involved and really sparked my interest in Myeloma Canada and motivated me to help with the incredible strides being made to support patients across the country. By creating awareness and gathering dedicated followers within our community, our team will continue to strive to make myeloma matter!”
The marches began in 2009 in Montreal, expanded to six cities last year, and this year will include Sault Ste. Marie, Halifax, Mississauga, Ottawa, St. John’s, Saguenay, Windsor, Winnipeg, Saskatoon and Quebec City.
“It’s essential for patients to know about treatment advances including drugs such as Revlimid and Velcade that are dramatically changing lives,” said Aldo Del Col, Co-founder & Executive Director of Myeloma Canada. “Dr. Donna Reece at Princess Margaret Hospital in Toronto has even reported that newer more tolerable drugs can be used for long term maintenance therapy that may eventually transform myeloma into a chronic disease. Nevertheless, myeloma is not curable and we need to support more research and fight for approval of even newer drugs as they become available.”
Further details can be found at www.myelomamarch.ca
About Myeloma Canada
Myeloma Canada is the only national organization exclusively devoted to the Canadian myeloma community. As a patient-driven, patient-focused organization, Myeloma Canada has been making myeloma matter since 2004, working with leading myeloma researchers and clinicians as well as other cancer organizations and local support groups across Canada. Myeloma Canada seeks to strengthen the voice of the Canadian myeloma community and improve the quality of life of myeloma patients, their caregivers and families through education, awareness, advocacy and research.
Myeloma Canada is making myeloma matter for the over 7,000 Canadians affected by this incurable, yet increasingly treatable cancer by:
· Providing educational resources and support to patients, their families and caregivers
· Increasing awareness of the disease and its effects on the lives of patients and families
· Advancing research and promoting access to new drug trials in Canada
· Facilitating access to new therapies, treatment options and health care resources
About Multiple Myeloma
Multiple myeloma (or simply myeloma) is a rare cancer of the bone marrow affecting production of red cells, white cells and platelets, and can lead to anemia, infections, renal failure, bone damage and severe pain. Every day, seven more Canadians are diagnosed with this incurable but increasingly treatable cancer.
New drugs have been successful in extending the lives of patients, but the reality is that myeloma remains a fatal disease and more needs to be done to advance the search for a cure.
For more information:
Jill Lang Ward
Co-Leader, 2012 Sault Ste. Marie Multiple Myeloma March
Home: 705-946-2960 Mobile: 705-971-3899